Medindia

X

Access Pharma Sponsors Oral Mucositis Symposium Today for MASCC Conference Attendees

Tuesday, June 22, 2010 Corporate News J E 4
Advertisement
Company Provides Update on MuGard(TM) Commercial Launch Activities

Contact: Company

Contact: Investor Relations

Christine Berni

Donald C. Weinberger/Diana Bittner (media)

Director of Investor Relations

Wolfe Axelrod Weinberger Assoc. LLC

Access Pharmaceuticals, Inc.

(212) 370-4500

(212) 786-6208

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Metabolex Enters Into Type 2 Diabetes Development ...
S
Probactive Biotech, Inc. Announces an Agreement to...